Keon Wook Kang Selected Research

Keon Wook Kang Research Topics

Disease

147	Neoplasms (Cancer) 04/2024 - 01/2002
56	Breast Neoplasms (Breast Cancer) 04/2024 - 10/2006
17	Neoplasm Metastasis (Metastasis) 01/2024 - 10/2006
13	Thyroid Neoplasms (Thyroid Cancer) 01/2023 - 04/2010
11	Lung Neoplasms (Lung Cancer) 04/2024 - 01/2012
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 07/2009
10	Fibrosis (Cirrhosis) 10/2023 - 01/2002
10	Liver Cirrhosis (Hepatic Cirrhosis) 04/2023 - 01/2002
10	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 06/2007
9	Hypoxia (Hypoxemia) 12/2023 - 06/2007
9	Inflammation (Inflammations) 12/2021 - 10/2002
8	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 08/2011
7	Glioma (Gliomas) 01/2023 - 11/2010
7	Carcinogenesis 01/2017 - 05/2002
5	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2023 - 12/2015
5	Triple Negative Breast Neoplasms 01/2022 - 10/2011
5	Melanoma (Melanoma, Malignant) 01/2020 - 01/2007
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2016 - 09/2005
5	Atherosclerosis 04/2014 - 08/2004
4	Papillary Thyroid Cancer 01/2023 - 05/2014
4	Non-alcoholic Fatty Liver Disease 01/2021 - 01/2016
4	Adenocarcinoma of Lung 08/2020 - 03/2013
3	Neointima 05/2023 - 06/2010
3	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 01/2012
3	Alcoholic Fatty Liver 12/2021 - 01/2019
3	Adenocarcinoma 11/2018 - 01/2015
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2018 - 07/2011
3	Lymphatic Metastasis 01/2018 - 02/2006

Drug/Important Bio-Agent (IBA)

31	Proteins (Proteins, Gene)FDA Link 10/2023 - 02/2002
29	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2022 - 02/2006
24	Tamoxifen FDA LinkGeneric 04/2024 - 06/2007
16	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 06/2011
13	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2024 - 09/2008
10	Estrogen ReceptorsIBA 12/2023 - 04/2008
10	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2012
8	ErbB Receptors (EGF Receptor)IBA 04/2024 - 05/2008
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 05/2008
7	AlbuminsIBA 11/2023 - 01/2019
7	Radioisotopes (Radionuclides)IBA 01/2023 - 08/2005
7	EnzymesIBA 01/2019 - 05/2002
6	Small Interfering RNA (siRNA)IBA 04/2024 - 05/2008
6	Antineoplastic Agents (Antineoplastics)IBA 11/2023 - 01/2008
6	IodineIBA 01/2023 - 07/2011
6	AntigensIBA 01/2022 - 04/2017
6	LigandsIBA 11/2021 - 08/2011
6	Fluorine-18IBA 04/2017 - 06/2012
6	AntioxidantsIBA 05/2016 - 08/2008
5	Cysteine (L-Cysteine)FDA Link 01/2023 - 02/2002
5	CytokinesIBA 01/2020 - 08/2004
5	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 06/2014 - 05/2008
5	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 10/2012 - 05/2008
4	Tyrosine Kinase InhibitorsIBA 04/2024 - 11/2016
4	IntegrinsIBA 04/2024 - 07/2011
4	CollagenIBA 10/2023 - 10/2002
4	Therapeutic UsesIBA 04/2023 - 01/2015
4	RNA (Ribonucleic Acid)IBA 01/2023 - 12/2019
4	Gefitinib (Iressa)FDA Link 01/2021 - 08/2015
4	Histone Deacetylase InhibitorsIBA 06/2020 - 04/2008
4	Methionine (L-Methionine)FDA Link 01/2020 - 08/2011
4	AcidsIBA 01/2020 - 01/2012
4	Peptides (Polypeptides)IBA 01/2020 - 03/2007
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2019 - 10/2010
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2019 - 01/2002
4	Messenger RNA (mRNA)IBA 11/2018 - 01/2010
4	sodium-iodide symporter (sodium iodide symporter)IBA 01/2017 - 04/2010
4	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2011 - 01/2009
4	NF-kappa B (NF-kB)IBA 10/2010 - 03/2009
4	oltiprazIBA 04/2009 - 01/2002
4	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2007 - 05/2003
3	Cisplatin (Platino)FDA LinkGeneric 11/2023 - 12/2019
3	Carbon Tetrachloride (Tetrachloromethane)IBA 04/2023 - 01/2018
3	Thioacetamide (Thioacetamid)IBA 03/2023 - 07/2019
3	Auranofin (Ridaura)FDA Link 03/2023 - 01/2019
3	Docetaxel (Taxotere)FDA Link 01/2023 - 10/2011
3	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2023 - 12/2015
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 05/2016
3	Histone Deacetylases (Histone Deacetylase)IBA 09/2022 - 04/2008
3	Estrogens (Estrogen)FDA Link 01/2022 - 08/2014
3	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 01/2019
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2021 - 01/2016
3	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 12/2020 - 12/2012
3	DNA (Deoxyribonucleic Acid)IBA 06/2020 - 11/2011
3	EstersIBA 01/2020 - 01/2012
3	Carrier Proteins (Binding Protein)IBA 01/2020 - 01/2019
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2019 - 07/2010
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 11/2019 - 12/2008
3	Hydroxyproline (4 Hydroxyproline)IBA 07/2019 - 10/2002
3	Interleukin-6 (Interleukin 6)IBA 07/2019 - 01/2007
3	p38 Mitogen-Activated Protein KinasesIBA 03/2019 - 01/2007
3	Tyrosine (L-Tyrosine)FDA Link 01/2017 - 12/2009
3	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 08/2016 - 02/2012
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2014 - 08/2004

Therapy/Procedure

30	Therapeutics 01/2024 - 10/2006
16	Drug Therapy (Chemotherapy) 10/2018 - 05/2007
8	Neoadjuvant Therapy 01/2018 - 04/2010
6	Immunotherapy 08/2022 - 03/2007
5	Radiotherapy 04/2020 - 12/2011
4	Liver Transplantation 11/2019 - 05/2009
3	Oral Administration 03/2023 - 10/2010
3	Precision Medicine 04/2020 - 06/2016